Catalyzing Change: The Business Imperative of Patient-Centric Drug Development

Summary: In this podcast, Dr Anthony Yanni, SVP, Head of Patient Centricity at Astellas, presented the business rationale for patient-centric medicine development, how it's disrupting the pharmaceutical industry and why companies have to act swiftly to remain competitive. Dr Yanni discusses how to align medicine development with healthcare delivery and the necessary cultural transformation that is critical to sustaining it, practical steps to incorporate patient input early into the R&D process, operationalizing patient-centric processes, methods to measure impact, and more.This presentation was recorded at the March 2025 Patients as Partners in Clinical Research conference. For more information, go to PatientsAsPartnersConference.com.